Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 246.69$. Average daily volumn in 3 months 1.37M. Market cap 74.38B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 255.75$. Total volume : 996.16k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
255.75$
Change
0.44
Volume
996.16k

Previous Close255.31
Open255.22
Day Range253.91-256.82
Bid0.00 x 900
Ask0.00 x 1.1k
Volume996.16k
Average Volume1.37M
Market Cap74.38B
Beta0.77
52 Week Range219.50-284.97
Trailing P/E45.57
Foward P/E19.57
Dividend (Yield %)1.30%
Ex-Dividend Date2021-09-08



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2020 were 17.12B an decrease(0%) over the years 2019 revenue that were of 17.29B. In 2020 the company's total earnings were 874M while total earnings in 2019 were 1.23B(-12.6%).


Loading ...



Organization

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Becton, Dickinson and Company_logo

Market Cap:
74.38B
Revenue:
17.12B
Total Assets:
54.01B
Total Cash:
2.83B


News about "Becton, Dickinson and Company"

Becton Dickinson faces first bellwether trial over hernia mesh_image

Becton Dickinson faces first bellwether trial over hernia mesh

Becton, Dickinson and Co subsidiary C.R. Bard will face trial on Monday over claims that its hernia repair surgical mesh is defective, offering the first test of the potential strength of thousands of ...

Source from : Reuters - 2 days ago


Becton, Dickinson And Company: Improved Return Prospects, It's A Buy

With indicative returns in the double digits, Becton, Dickinson is a buy. The company has three operating segments, BD Medical, BD Life Sciences and BD Interventional. Figure 1 below extracted ...

Source from : Seeking Alpha - 1 month ago


Becton Dickinson Snaps Up Velano Vascular

M edical technology giant Becton, Dickinson and Company has acquired San Francisco-based Velano Vascular to make its vision of a 'One-Stick Hospital Stayโ€™ a reality. The financi ...

Source from : Nasdaq - 13 days ago


Ventilator Market Technology Advancement and Business Outlook 2031 | By Share, Size, Growth | Becton, Dickinson and Company, Draeger Medical_image

Ventilator Market Technology Advancement and Business Outlook 2031 | By Share, Size, Growth | Becton, Dickinson and Company, Draeger Medical

The latest insightSLICE research report published on Ventilator promises to cede reliable and clarifying insights appertaining to the real time scenario trajectory concerning the market arena during ...

Source from : manometcurrent.com - 13 days ago


Becton, Dickinson acquires Tepha for driving new innovations in soft tissue repair and regeneration

Marking its sixth tuck-in acquisition of FY21, Becton, Dickinson (BDX)ย acquired Tepha, developer and manufacturer of a proprietary resorbable polymer technology; transaction terms ...

Source from : Seeking Alpha - 6 days ago


Becton, Dickinson and Co BDXB

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Source from : Morningstar%2c Inc. - 28 days ago


Insulin Delivery Systems Market Size, CAGR | Key Players โ€“ Becton, Dickinson and Company, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company_image

Insulin Delivery Systems Market Size, CAGR | Key Players โ€“ Becton, Dickinson and Company, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company

Request Download Sample Ask For Discount Company Profile. New Jersey, United States,- The Insulin Delivery Systems Market has experienced remarkable dynamism in recent years. The ...

Source from : manometcurrent.com - 7 days ago


Catheter Market with Relevancy Mapping by Key Player like Abbott Laboratories, Becton Dickinson And Company

New statistical research by Marketresearch.biz on Catheter Market 2021 will show you the latest industry insights on future trends, product research, and service analysis, allowing you to penetrate ...

Source from : MarketWatch - 10 days ago


Becton, Dickinson and Co BOX

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Source from : Morningstar%2c Inc. - 26 days ago


Blood Transfusion Devices Market is Projected to Showcase Significant Growth up to 2027 Covid-19 Analysis | Cerus, Becton Dickinson_image

Blood Transfusion Devices Market is Projected to Showcase Significant Growth up to 2027 Covid-19 Analysis | Cerus, Becton Dickinson

To make market monitoring and sale services easier this Blood Transfusion Devices market Report concentrates on key market segments It will also help you attract different types of customers by ...

Source from : openpr.com - 5 days ago


Blood Lancet Market Report, Key Players, Size, Share, Analysis 2021 and Forecast To 2027 | Becton Dickinson, Improve Medical, Terumo_image

Blood Lancet Market Report, Key Players, Size, Share, Analysis 2021 and Forecast To 2027 | Becton Dickinson, Improve Medical, Terumo

The report titled Global Blood Lancet Market is one of the most comprehensive and important additions to QY Research s archive of market research studies It offers detailed research and analysis of ...

Source from : openpr.com - 4 days ago


Breast Biopsy Devices Market- Argon Medical Devices Inc., and Becton, Dickinson and Co., to contribute to the market growth|Technavio

The breast biopsy devices market is poised to grow by USD 590.30 million during 2021-2025, progressing at a CAGR of about 11% during the forecast period. The report on the breast biopsy devices ...

Source from : Benzinga.com - 26 days ago


Becton, Dickinson and Company (NYSE:BDX) Shares Could Be 27% Below Their Intrinsic Value Estimate

In this article we are going to estimate the intrinsic value of Becton, Dickinson and Company (NYSE:BDX) by estimating the company's future cash flows and discounting them to their present value. Our ...

Source from : Yahoo Finance - 17 days ago


Cell Culture Media and Reagents Market growth analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio_image

Cell Culture Media and Reagents Market growth analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio

The cell culture media and reagents market is set to grow by USD 2.26 billion, progressing at a CAGR of about 7% during ...

Source from : WFMZ-TV - 11 days ago


Global Lateral Flow Assay Market 2021 Future Scenario and Major Growth by Key Players - Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson

NewLine; MRInsights.biz has published a new report titled Global Lateral Flow Assay Market Growth (Status and Outlook) 2021-2026 that is designed and articulated on the ...

Source from : Big News Network.com - 11 days ago


Therapeutic Respirator Devices Market Report 2021, Focusing on Leading Players - AirSep Corporation, Breas Medical, Becton, Dickinson and Company etc.

The product flow and distribution channel have also been presented in this research report. Therapeutic Respirator Devices Market 2021 The latest research report on Therapeutic Respirator Devices ...

Source from : ARN - 20 days ago


Microbial Identification Market In-Depth Analysisโ€ฆ

This section reveals their current market standings, along with an analysis of key undertakings and notable developments of each company being profiled. Primary and secondary research have extensively ...

Source from : PharmiWeb - 26 days ago


Infectious Disease Testing Market Report 2021, Focusing on Leading Players - Abbott Laboratories, Becton, Dickinson and Company, Biomรฉrieux SA etc.

The product flow and distribution channel have also been presented in this research report. Infectious Disease Testing Market 2021 The latest research report on Infectious Disease Testing market ...

Source from : Reseller News - 20 days ago


Breast Biopsy Devices Market- Argon Medical Devices Inc., and Becton, Dickinson and Co., to contribute to the market growth|Technavio

ยฉ 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...

Source from : Business Insider - 26 days ago


Breast Biopsy Devices Market- Argon Medical Devices Inc., and Becton, Dickinson and Co., to contribute to the market growth|Technavio

The breast biopsy devices market is poised to grow by USD 590.30 million during 2021-2025, progressing at a CAGR of about 11% during the forecast period. View our exclusive report on market scenarios, ...

Source from : Yahoo Finance - 26 days ago


Therapeutic Respirator Devices Market Investment Analysis, Major Keyplayers - AirSep Corporation, Breas Medical, Becton, Dickinson and Company etc.

The Research Report covers all the necessary information and remarkable data required by new market entrants as well as the existing players to gain a deeper insight into the market. Therapeutic ...

Source from : ARN - 27 days ago


Becton Dickinson and Company (BDX) Upgraded Issued by Wall Street Gurus_image

Becton Dickinson and Company (BDX) Upgraded Issued by Wall Street Gurus

Becton Dickinson and Company (NYSE:BDX) went down by -0.26% from its latest closing price compared to the recent 1-year high of $284.97. The companyโ€™s stock price has collected 0.14% of gains in the ...

Source from : newsheater - 2 month ago


Where Do Hedge Funds Stand On Becton, Dickinson and Company (BDX)?

In this article, we analyze how these elite funds and prominent investors traded Becton, Dickinson and Company (NYSE:BDX) based on those filings. At the moment there are several metrics market ...

Source from : Insider Monkey - 1 month ago


Global Vaccines Delivery Market 2021 Regional Analysis with Forecast | Becton Dickinson and Company (BD), BioCSL, Novavax Inc., Vaxart Inc.

The latest business report titled Global Vaccines Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026 issued by MarketQuest.biz is the finest fabrication of trust and ...

Source from : Digital Journal - 1 month ago


Becton, Dickinson PE Ratio:

This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have ...

Source from : YCharts - 1 month ago


Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and ...

Source from : Reuters - 11 month ago


Becton, Dickinson and Company

minimum of 10 words Downers - What were the worst aspects of your internship? minimum of 10 words What additional information can you provide potential candidates seeking an internship at this company ...

Source from : Vault - 2 years ago


Becton, Dickinson And Co.

The best cryptocurrency to buy largely depends on your risk tolerance and technical know-how.

Source from : U.S. News & World Report - 1 year ago


BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration_image

BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading developer and manufacturer of a proprietary ...

Source from : YAHOO!Finance - 6 days ago


BD Picks Up Resorbable Polymer Company

BD will use Tepha Inc.โ€™s proprietary resorbable polymer platform to spur growth in its surgical mesh products and develop soft-tissue repair technology.

Source from : Plastics Today - 5 days ago


BD to Present at UBS Genomics 2.0 and MedTech Innovations Summit

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that management will be presenting at the UBS Genomics 2.0 and MedTech Innovations Summit ...

Source from : Yahoo - 3 days ago


Interesting BDX Put And Call Options For September 3rd

Investors in Becton, Dickinson & Co (Symbol: BDX) saw new options become available today, for the September 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Source from : Nasdaq - 10 days ago


Healthcare Life Science & Chemical Instrumentation Market Size, Share, Outlook, and Opportunity Analysis to 2027

The scope of the report includes a detailed study of global and regional markets for Global Healthcare Life Science ...

Source from : MarketWatch - 3 days ago


Free and Charitable Clinics Receive Grant for Point-of-Care Diagnostics_image

Free and Charitable Clinics Receive Grant for Point-of-Care Diagnostics

BD, Heart to Heart International and the NAFC Announce 2020/2021 Grantees for Multi-YearDiagnostic Testing Initiative to Improve Patient Outcomes Point of Care, Enhancing Clinical Effectiveness ...

Source from : YAHOO!Finance - 13 days ago


The Globe and Mail

FRANKLIN LAKES, N.J., June 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today issued its 2020 Sustainability Report ...

Source from : The Globe and Mail - 1 month ago


BD Announces Two Future Directors for Diabetes Care Spinoff Company

FRANKLIN LAKES, N.J., July 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that David F. Melcher will be non ...

Source from : PR Newswire - 21 days ago


BD Launches Reimagined Digital Marketplace for Flow Cytometry

FRANKLIN LAKES, N.J., July 7, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new ...

Source from : WFMZ-TV - 26 days ago


Vial and Bottle Market: An Exclusive Study on Upcoming Trends and Growth Opportunities

Opportunities in the vial and bottle market have evolved through a number of stages. Lucintel has found the future of this market to be promising; the vial and bottle market is expected to reach $22.8 ...

Source from : Inter Press Service - 5 days ago


The Globe and Mail

FRANKLIN LAKES, N.J., July 7, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the commercial release of a new ...

Source from : The Globe and Mail - 24 days ago


5 Best Dividend Stocks to Buy According to Al Gore and David Blood

Becton, Dickinson and Company (NYSE: BDX) is engaged in trading first-aid supplies, appliances, laboratory kits, and diagnostic products globally. The company was founded in 1897 and ranks fifth ...

Source from : Insider Monkey - 1 month ago


Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory

Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Joseph Hutson as its Vice President of Quality and Regulatory. Hutson brings 23 years of experience in the life sciences ...

Source from : Associated Press - 11 days ago


BD Highlights Five-Year ESG Achievements in 2020 Sustainability Report, Setting the Foundation for 2030+ Strategy

FRANKLIN LAKES, N.J., June 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2020 Sustainability Report ...

Source from : PR Newswire - 1 month ago


BD Announces Expanded 510(k) Clearance for At-Home System for Ascites

ยฉ 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...

Source from : Business Insider - 1 month ago


2 Cheap Dividend Stocks You Can Buy Right Now

Becton, Dickinson (BD) is a Dividend Aristocrat that ... given its likelihood to increase its payouts. The company is coming off a year of mixed results. Over the six-month period ending March ...

Source from : The Motley Fool - 1 month ago


BDโ€™s Vision One Step Closer to Becoming Reality

Becton Dickinson and Co. has acquired Velano Vascular to help its vision of a "One-Stick Hospital Stay,โ€ come into fruition. The companies did not disclose financial terms of the deal. Velanoโ€™s needle ...

Source from : MD&M East - 14 days ago


BD To Announce Financial Results For Its Third Quarter Of Fiscal 2021

FRANKLIN LAKES, N.J., June 30, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the third quarter of fiscal year ...

Source from : Benzinga.com - 1 month ago